Physician profile
Tyler Cheung
NPI 1790993590
$23,265.61
in general payments reported to CMS, 2019-2025
73 companies · $5,160 in 2025
The $5,160 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,945 · 2020: $1,740 · 2021: $3,212 · 2022: $3,626 · 2023: $3,762 · 2024: $3,821 · 2025: $5,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $87.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,655.43 |
| Education | $87.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,923.89 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $2,360.75 | 2019-2025 | Botox, Ubrelvy, Duopa |
| Ucb, INC. | $1,718.54 | 2019-2025 | Fintepla, Rystiggo, Zilbrysq |
| Neurocrine Biosciences, INC. | $1,324.73 | 2019-2025 | Ingrezza |
| Boston Scientific Corporation | $988.48 | 2023-2025 | General - Dbs |
| Amneal Pharmaceuticals LLC | $951.98 | 2019-2025 | Rytary, Crexont |
| Lundbeck LLC | $816.29 | 2019-2025 | Vyepti |
| Eisai INC. | $798.24 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $716.03 | 2019-2025 | Ultomiris, Soliris |
| Abbott Laboratories | $684.99 | 2019-2025 | Infinity, Amplatzer Piccolo, Amplatzer |
| Acadia Pharmaceuticals INC | $656.56 | 2019-2025 | Nuplazid |
| Lilly USA, LLC | $633.36 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Novartis Pharmaceuticals Corporation | $605.44 | 2019-2025 | |
| Sk Life Science, INC. | $575.78 | 2020-2025 | |
| Celgene Corporation | $568.56 | 2021-2025 | Zeposia |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.